Hemoglobinopathies Market Scope 2031
The Hemoglobinopathies Market is expected to register a CAGR of 11.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is divided into four sections: Application (Thalassemia, Sickle Cell Disease), Diagnostic (Hemoglobin Isoelectric Focusing, Hemoglobin Electrophoresis, High Performance Liquid Chromatography, Genetic Testing, Hemoglobin Solubility Test) and End User (Hospitals, Diagnostic Laboratories, Research Laboratories). The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Hemoglobinopathies Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Hemoglobinopathies Market Segmentation
Application- Thalassemia
- Sickle Cell Disease
- Hemoglobin Isoelectric Focusing
- Hemoglobin Electrophoresis
- High Performance Liquid Chromatography
- Genetic Testing
- Hemoglobin Solubility Test
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Hemoglobinopathies Market Growth Drivers- Increasing prevalence of hemoglobinopathies: The global burden of hemoglobinopathies, such as sickle cell disease and thalassemia, is significant and rising. This increase in affected individuals drives the demand for effective treatments and fuels market growth.
- Advancements in diagnostic technologies: Improved diagnostic tools enable earlier and more accurate detection of hemoglobinopathies, leading to timely interventions and better patient outcomes. This also contributes to market expansion.
- Emerging gene therapies and stem cell transplantation: Novel gene editing techniques and advancements in stem cell transplantation offer promising curative potential for hemoglobinopathies. These innovative therapies are driving significant growth in the market.
- Personalized medicine approaches: Tailoring treatment strategies to individual patient needs and genetic profiles is becoming increasingly important. This personalized approach is expected to improve treatment outcomes and drive market growth.
- Focus on rare hemoglobinopathies: While sickle cell disease and thalassemia are the most prevalent, many rare hemoglobinopathies also exist. Increasing attention to these rare conditions will create new opportunities for research, development, and market expansion.
- Expansion of newborn screening programs: Widespread implementation of newborn screening programs can lead to earlier diagnosis and intervention, improving long-term health outcomes for individuals with hemoglobinopathies. This expansion will further contribute to market growth.
- Development of novel gene editing therapies: Continued research and development of gene editing technologies like CRISPR-Cas9 hold immense potential for developing curative therapies for hemoglobinopathies. This area presents significant opportunities for market growth.
- Exploration of combination therapies: Combining different treatment approaches, such as gene therapy with supportive care or transplantation, may offer synergistic benefits and improved outcomes for patients. Exploring these combination therapies presents new market opportunities.
- Expansion into emerging markets: Many countries with high prevalence of hemoglobinopathies have emerging healthcare markets. Expanding access to effective treatments in these regions presents significant commercial opportunities for the hemoglobinopathies market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Hemoglobinopathies Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Hemoglobinopathies Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Hemoglobinopathies Market is expected to grow at a CAGR of 11.5% between 2023-2031
The driving factors impacting the Hemoglobinopathies Market are: Increasing prevalence of hemoglobinopathies, Advancements in diagnostic technologies, Emerging gene therapies and stem cell transplantation
The future trends of the Hemoglobinopathies Market are: Personalized medicine approaches, Focus on rare hemoglobinopathies and Expansion of newborn screening programs
The leading players of the market are: Bio-Rad Laboratories, Inc, PerkinElmer Inc, EKF Diagnostics, ThermoFisher Scienific Corporation Inc, Siemens Healthcare GmbH, Sebia, Novus Biologicals, Chromsystems Instruments and Chemicals GmbH, PerkinElmer Inc, HemoCue AB (Danaher Company)
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hemoglobinopathies Market - By Application
1.3.2 Hemoglobinopathies Market - By Diagnostic
1.3.3 Hemoglobinopathies Market - By End User
1.3.4 Hemoglobinopathies Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HEMOGLOBINOPATHIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMOGLOBINOPATHIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HEMOGLOBINOPATHIES MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMOGLOBINOPATHIES - GLOBAL MARKET OVERVIEW
6.2. HEMOGLOBINOPATHIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMOGLOBINOPATHIES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. THALASSEMIA
7.3.1. Overview
7.3.2. Thalassemia Market Forecast and Analysis
7.4. SICKLE CELL DISEASE
7.4.1. Overview
7.4.2. Sickle Cell Disease Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. HEMOGLOBINOPATHIES MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSTIC
8.1. OVERVIEW
8.2. DIAGNOSTIC MARKET FORECASTS AND ANALYSIS
8.3. HEMOGLOBIN ISOELECTRIC FOCUSING
8.3.1. Overview
8.3.2. Hemoglobin Isoelectric Focusing Market Forecast and Analysis
8.4. HEMOGLOBIN ELECTROPHORESIS
8.4.1. Overview
8.4.2. Hemoglobin Electrophoresis Market Forecast and Analysis
8.5. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
8.5.1. Overview
8.5.2. High Performance Liquid Chromatography Market Forecast and Analysis
8.6. GENETIC TESTING
8.6.1. Overview
8.6.2. Genetic Testing Market Forecast and Analysis
8.7. HEMOGLOBIN SOLUBILITY TEST
8.7.1. Overview
8.7.2. Hemoglobin Solubility Test Market Forecast and Analysis
9. HEMOGLOBINOPATHIES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORIES
9.4.1. Overview
9.4.2. Diagnostic Laboratories Market Forecast and Analysis
9.5. RESEARCH LABORATORIES
9.5.1. Overview
9.5.2. Research Laboratories Market Forecast and Analysis
10. HEMOGLOBINOPATHIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hemoglobinopathies Market Overview
10.1.2 North America Hemoglobinopathies Market Forecasts and Analysis
10.1.3 North America Hemoglobinopathies Market Forecasts and Analysis - By Application
10.1.4 North America Hemoglobinopathies Market Forecasts and Analysis - By Diagnostic
10.1.5 North America Hemoglobinopathies Market Forecasts and Analysis - By End User
10.1.6 North America Hemoglobinopathies Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hemoglobinopathies Market
10.1.6.1.1 United States Hemoglobinopathies Market by Application
10.1.6.1.2 United States Hemoglobinopathies Market by Diagnostic
10.1.6.1.3 United States Hemoglobinopathies Market by End User
10.1.6.2 Canada Hemoglobinopathies Market
10.1.6.2.1 Canada Hemoglobinopathies Market by Application
10.1.6.2.2 Canada Hemoglobinopathies Market by Diagnostic
10.1.6.2.3 Canada Hemoglobinopathies Market by End User
10.1.6.3 Mexico Hemoglobinopathies Market
10.1.6.3.1 Mexico Hemoglobinopathies Market by Application
10.1.6.3.2 Mexico Hemoglobinopathies Market by Diagnostic
10.1.6.3.3 Mexico Hemoglobinopathies Market by End User
10.2. EUROPE
10.2.1 Europe Hemoglobinopathies Market Overview
10.2.2 Europe Hemoglobinopathies Market Forecasts and Analysis
10.2.3 Europe Hemoglobinopathies Market Forecasts and Analysis - By Application
10.2.4 Europe Hemoglobinopathies Market Forecasts and Analysis - By Diagnostic
10.2.5 Europe Hemoglobinopathies Market Forecasts and Analysis - By End User
10.2.6 Europe Hemoglobinopathies Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hemoglobinopathies Market
10.2.6.1.1 Germany Hemoglobinopathies Market by Application
10.2.6.1.2 Germany Hemoglobinopathies Market by Diagnostic
10.2.6.1.3 Germany Hemoglobinopathies Market by End User
10.2.6.2 France Hemoglobinopathies Market
10.2.6.2.1 France Hemoglobinopathies Market by Application
10.2.6.2.2 France Hemoglobinopathies Market by Diagnostic
10.2.6.2.3 France Hemoglobinopathies Market by End User
10.2.6.3 Italy Hemoglobinopathies Market
10.2.6.3.1 Italy Hemoglobinopathies Market by Application
10.2.6.3.2 Italy Hemoglobinopathies Market by Diagnostic
10.2.6.3.3 Italy Hemoglobinopathies Market by End User
10.2.6.4 Spain Hemoglobinopathies Market
10.2.6.4.1 Spain Hemoglobinopathies Market by Application
10.2.6.4.2 Spain Hemoglobinopathies Market by Diagnostic
10.2.6.4.3 Spain Hemoglobinopathies Market by End User
10.2.6.5 United Kingdom Hemoglobinopathies Market
10.2.6.5.1 United Kingdom Hemoglobinopathies Market by Application
10.2.6.5.2 United Kingdom Hemoglobinopathies Market by Diagnostic
10.2.6.5.3 United Kingdom Hemoglobinopathies Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hemoglobinopathies Market Overview
10.3.2 Asia-Pacific Hemoglobinopathies Market Forecasts and Analysis
10.3.3 Asia-Pacific Hemoglobinopathies Market Forecasts and Analysis - By Application
10.3.4 Asia-Pacific Hemoglobinopathies Market Forecasts and Analysis - By Diagnostic
10.3.5 Asia-Pacific Hemoglobinopathies Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hemoglobinopathies Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hemoglobinopathies Market
10.3.6.1.1 Australia Hemoglobinopathies Market by Application
10.3.6.1.2 Australia Hemoglobinopathies Market by Diagnostic
10.3.6.1.3 Australia Hemoglobinopathies Market by End User
10.3.6.2 China Hemoglobinopathies Market
10.3.6.2.1 China Hemoglobinopathies Market by Application
10.3.6.2.2 China Hemoglobinopathies Market by Diagnostic
10.3.6.2.3 China Hemoglobinopathies Market by End User
10.3.6.3 India Hemoglobinopathies Market
10.3.6.3.1 India Hemoglobinopathies Market by Application
10.3.6.3.2 India Hemoglobinopathies Market by Diagnostic
10.3.6.3.3 India Hemoglobinopathies Market by End User
10.3.6.4 Japan Hemoglobinopathies Market
10.3.6.4.1 Japan Hemoglobinopathies Market by Application
10.3.6.4.2 Japan Hemoglobinopathies Market by Diagnostic
10.3.6.4.3 Japan Hemoglobinopathies Market by End User
10.3.6.5 South Korea Hemoglobinopathies Market
10.3.6.5.1 South Korea Hemoglobinopathies Market by Application
10.3.6.5.2 South Korea Hemoglobinopathies Market by Diagnostic
10.3.6.5.3 South Korea Hemoglobinopathies Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hemoglobinopathies Market Overview
10.4.2 Middle East and Africa Hemoglobinopathies Market Forecasts and Analysis
10.4.3 Middle East and Africa Hemoglobinopathies Market Forecasts and Analysis - By Application
10.4.4 Middle East and Africa Hemoglobinopathies Market Forecasts and Analysis - By Diagnostic
10.4.5 Middle East and Africa Hemoglobinopathies Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hemoglobinopathies Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hemoglobinopathies Market
10.4.6.1.1 South Africa Hemoglobinopathies Market by Application
10.4.6.1.2 South Africa Hemoglobinopathies Market by Diagnostic
10.4.6.1.3 South Africa Hemoglobinopathies Market by End User
10.4.6.2 Saudi Arabia Hemoglobinopathies Market
10.4.6.2.1 Saudi Arabia Hemoglobinopathies Market by Application
10.4.6.2.2 Saudi Arabia Hemoglobinopathies Market by Diagnostic
10.4.6.2.3 Saudi Arabia Hemoglobinopathies Market by End User
10.4.6.3 U.A.E Hemoglobinopathies Market
10.4.6.3.1 U.A.E Hemoglobinopathies Market by Application
10.4.6.3.2 U.A.E Hemoglobinopathies Market by Diagnostic
10.4.6.3.3 U.A.E Hemoglobinopathies Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hemoglobinopathies Market Overview
10.5.2 South and Central America Hemoglobinopathies Market Forecasts and Analysis
10.5.3 South and Central America Hemoglobinopathies Market Forecasts and Analysis - By Application
10.5.4 South and Central America Hemoglobinopathies Market Forecasts and Analysis - By Diagnostic
10.5.5 South and Central America Hemoglobinopathies Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hemoglobinopathies Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hemoglobinopathies Market
10.5.6.1.1 Brazil Hemoglobinopathies Market by Application
10.5.6.1.2 Brazil Hemoglobinopathies Market by Diagnostic
10.5.6.1.3 Brazil Hemoglobinopathies Market by End User
10.5.6.2 Argentina Hemoglobinopathies Market
10.5.6.2.1 Argentina Hemoglobinopathies Market by Application
10.5.6.2.2 Argentina Hemoglobinopathies Market by Diagnostic
10.5.6.2.3 Argentina Hemoglobinopathies Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HEMOGLOBINOPATHIES MARKET, KEY COMPANY PROFILES
12.1. BIO-RAD LABORATORIES, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PERKINELMER INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EKF DIAGNOSTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMOFISHER SCIENIFIC CORPORATION INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SIEMENS HEALTHCARE GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SEBIA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVUS BIOLOGICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CHROMSYSTEMS INSTRUMENTS AND CHEMICALS GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PERKINELMER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HEMOCUE AB (DANAHER COMPANY)
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Bio-Rad Laboratories, Inc
2. PerkinElmer Inc
3. EKF Diagnostics
4. ThermoFisher Scienific Corporation Inc
5. Siemens Healthcare GmbH
6. Sebia
7. Novus Biologicals
8. Chromsystems Instruments and Chemicals GmbH
9. PerkinElmer Inc
10. HemoCue AB (Danaher Company)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For